Semler Scientific Reports Strong Preliminary Fourth Quarter Financial Results and Impressive Bitcoin Holdings Gains

Semler Scientific's Preliminary Fourth Quarter Results for 2024

Semler Scientific, Inc. (Nasdaq: SMLR), a company at the forefront of developing innovative technology solutions for healthcare providers in the fight against chronic diseases, recently released its preliminary unaudited financial performance for the fourth quarter of 2024. The report revealed promising figures and a noteworthy increase in Bitcoin holdings, underscoring the company’s robust growth trajectory.

Financial Performance Highlights

In the preliminary results announced on January 23, 2025, Semler reported a projected revenue range of $12.1 million to $12.5 million for the fourth quarter. This performance has been driven by strong operational efficiency, as indicated by an expected income from operations between $3.4 million to $3.7 million. Notably, the financial results reflect the strategic decisions the company has made to enhance its operations and maximize profitability.

Moreover, Semler Scientific recorded a staggering unrealized gain of approximately $28.9 million from the change in fair value of its Bitcoin holdings, illustrating the significant impact of cryptocurrency on the company’s overall financial health. As of January 17, 2025, the company owned 2,321 bitcoins, acquired at a total cost of roughly $191.9 million, showcasing a calculated approach to investing in this volatile digital asset.

CEO’s Insights

Doug Murphy-Chutorian, M.D., the Chief Executive Officer of Semler Scientific, expressed optimism about the company’s performance. “We are thrilled to share these preliminary numbers and significant unrealized gains from our Bitcoin holdings,” he stated. He emphasized the company’s commitment to implementing a strategic bitcoin treasury approach, which has gained traction in the investment community. This move not only adds another layer to Semler’s business strategy but may also position the company favorably in the financial markets as interest in cryptocurrency gains momentum.

Upcoming Full Financial Report

The complete financial results for the fourth quarter and the full year ending December 31, 2024, will be disclosed following the market close on February 18, 2025. This announcement is expected to provide further insights into Semler Scientific’s operational performance and future strategies. Following the announcement, Dr. Murphy-Chutorian will lead a conference call at 4:30 PM ET, providing an opportunity for the investment community to gain more clarity regarding the company's direction and financial management.

Conclusion

Semler Scientific's preliminary earnings report positions the company as a resilient player in the healthcare technology sector. With its innovative product offerings aimed at addressing chronic diseases, robust operational strategies, and strategic utilization of cryptocurrency, Semler is set to make waves in the upcoming financial year. Investors and stakeholders alike will be keenly observing the forthcoming comprehensive results and the conference call for any additional guidance and insights. The health tech industry is watching closely as Semler navigates these waters, solidifying its position as a leader in both healthcare solutions and cryptocurrency investment.

For more information, one can follow up on the conference call details and pre-register through the provided link on Semler Scientific’s official website.